These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4174897)

  • 21. Studies on further attenuated live measles vaccine. V. Immunization test of CAM-A4 measles vaccine on handicapped children.
    Ueda S; Okuno Y; Sakamoto Y
    Biken J; 1970 Sep; 13(3):175-8. PubMed ID: 4249672
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of hemagglutination inhibition tests for the determination of measles antibodies. I. Determination of measles antibodies in sera of children vaccinated against measles].
    Kolchurina AA; Semen'kova LI
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():266-72. PubMed ID: 5860947
    [No Abstract]   [Full Text] [Related]  

  • 23. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
    Arrouji A; Mirchamsy H; Marnissi A
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
    [No Abstract]   [Full Text] [Related]  

  • 24. Modifications of IFN-alpha, TNF-alpha and IFN-gamma serum levels in children vaccinated against measles.
    Liguori G; Tolone C; D'Avanzo M; Corbisiero G; Di Benedetto R; Del Prete U
    Ann Ig; 1998; 10(5-6):303-6. PubMed ID: 10052194
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of hemagglutination inhibition tests for the determination of measles antibodies. II. Determination of measles antibodies in commercial gamma-globulin].
    Kolchurina AA; Semen'kova LI
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():273-9. PubMed ID: 4159437
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on measles in Thailand. IV. Persistence of measles antibody in the absence of natural virus two years after vaccination by the "KL" method.
    Sangkawibha N; Tsuchida P; Bukkavesa S; Ostanonda P; Ueda S
    Biken J; 1971 Jun; 14(2):149-54. PubMed ID: 5122205
    [No Abstract]   [Full Text] [Related]  

  • 27. [Duration of immunity and delayed skin hypersensitivity in patients vaccinated against measles].
    Veronesi R; Penna HA; Issler H
    Rev Hosp Clin Fac Med Sao Paulo; 1970; 25(1):33-8. PubMed ID: 5422695
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies on immunity to measles. II. Prophylactic and serological studies on the use of live and attenuated measles-virus vaccine].
    Egami T
    Kumamoto Igakkai Zasshi; 1966 May; 40(5):539-62. PubMed ID: 4164172
    [No Abstract]   [Full Text] [Related]  

  • 29. [Atypical measles experienced in 1970].
    Seki T; Hara M; Miyazaki Y; Chiba H; Yokota K
    Nihon Shonika Gakkai Zasshi; 1971 Jun; 75(6):440-5. PubMed ID: 5104630
    [No Abstract]   [Full Text] [Related]  

  • 30. Development and evaluation of the Moraten measles virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J; Whitman JE; Leagus MB
    JAMA; 1968 Oct; 206(3):587-90. PubMed ID: 5695578
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies of specific measles prevention].
    Cajal N; Cepleanu M; Sorodoc Y; Cernescu C; Manu S; Weintraub B; Lucian M; Popescu M
    Stud Cercet Inframicrobiol; 1970; 21(3):195-211. PubMed ID: 5455840
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of two live measles vaccines in virgin populations in arctic Greenland. Clinical and serological reactions in children and adults.
    Mordhorst CH; Tulinius S; von Magnus H
    Dan Med Bull; 1968 Nov; 15(9):263-70. PubMed ID: 4102838
    [No Abstract]   [Full Text] [Related]  

  • 33. [Research of hemoagglutinoinhibiting antibodies against measles virus in a sample of population from Accra (Ghana)].
    Balestrieri A; D'Arrigo C; Russo V
    Arch Ital Sci Med Trop Parassitol; 1968; 49(1):49-54. PubMed ID: 5740693
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative evaluation of 3 measles vaccines. 3. Evaluation of the hemagglutination inhibition test for assaying measles antibodies after vaccination].
    Polna I; Naruszewicz-Lesiuk D; Pilecka T
    Przegl Epidemiol; 1970; 24(3):339-47. PubMed ID: 5482214
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine.
    Weibel RE; Stokes J; Buynak EB; Leagus MB; Hilleman MR
    Pediatrics; 1969 Apr; 43(4):567-72. PubMed ID: 4304934
    [No Abstract]   [Full Text] [Related]  

  • 36. Measles vaccination in Iceland: three-year follow-up of antibody titres in adults and children.
    Black FL; Gudnadóttir M
    Bull World Health Organ; 1966; 35(6):955-7. PubMed ID: 4165239
    [No Abstract]   [Full Text] [Related]  

  • 37. [Vaccination against measles].
    Cocchi P; Corti R
    Pediatr Med Chir; 1984; 6(1):5-11. PubMed ID: 6085156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status of measles immunization.
    JAMA; 1965 Dec; 194(11):1237-8. PubMed ID: 4158503
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of the levels of immunoglobulins G,A,M,D and hemagglutination inhibition antibodies in the serum during rubeola in childhood].
    Wiedermannová D; Wiedermann D; Hatiarová Z; Novotná D
    Cesk Pediatr; 1974 Jan; 29(1):34-7. PubMed ID: 4452136
    [No Abstract]   [Full Text] [Related]  

  • 40. [Measles antibody levels in selected Polish provinces].
    Polna I
    Przegl Epidemiol; 1971; 25(2):251-6. PubMed ID: 5569338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.